Guinea
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 13 (6.61 - 21.79) | 2015 | Modelled | WHO |
| 15.06 (14.16 - 16.01) | 2013 | Modelled | Schweitzer et al, 2015 |
| 11.74 (9.47 - 13.58) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 12.88 (10.47 - 14.77) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.16 (10.54 - 15.28) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.58 (10.90 - 15.66) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.92 (11.14 - 16.28) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.04 (11.26 - 16.22) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.35 (11.61 - 16.48) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.73 (12 - 16.91) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.05 (12.35 - 17.32) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.19 (12.50 - 17.76) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.31 (12.50 - 17.76) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.6 (12.61 - 18.13) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.96 (12.63 - 18.67) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.25 (12.77 - 19.14) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.39 (12.70 - 19.44) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.41 (12.77 - 19.33) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.41 (12.91 - 19.12) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.41 (13 - 19.02) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.43 (13.08 - 19.02) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.48 (13.11 - 19.20) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 16.67 (13.22 - 19.28) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.01 (13.37 - 19.81) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.39 (13.52 - 20.38) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.71 (13.62 - 20.96) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.85 (13.67 - 21.19) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.87 (13.77 - 20.99) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.87 (13.88 - 20.90) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.84 (13.95 - 20.67) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.78 (13.96 - 20.59) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.67 (13.95 - 20.48) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.38 (10.05 - 14.32) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 7.47 (3.70 - 13.98) | 2015 | Modelled | WHO |
| 6.36 (4.26 - 8.06) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 6.9 (4.64 - 8.71) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.71 (5.01 - 9.56) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.04 (5.15 - 10.11) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.89 (5.04 - 9.98) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.65 (4.87 - 9.85) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.38 (4.72 - 9.46) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.03 (4.49 - 9) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.68 (4.31 - 8.64) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.41 (4.12 - 8.37) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.3 (4.04 - 8.44) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.04 (4.56 - 9.27) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.83 (5.72 - 11.43) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.98 (7.04 - 14.11) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.81 (8.19 - 16.43) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.66 (8.76 - 17.58) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.75 (9.04 - 17.35) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.77 (9.20 - 17.21) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.76 (9.36 - 17.16) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.77 (9.48 - 17.31) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.82 (9.49 - 17.55) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.03 (9.66 - 17.66) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.41 (9.72 - 18.24) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.82 (9.65 - 19.01) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.15 (9.76 - 19.83) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.3 (9.80 - 20.19) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.29 (9.78 - 20.03) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.27 (9.82 - 19.85) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.23 (9.81 - 19.75) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 15.13 (9.71 - 19.46) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 14.99 (9.62 - 19.11) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.07 (5.10 - 7.24) | 2020 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 1,484,250 (1,197,090 - 1,717,540) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 1,527,750 (1,243,090 - 1,766,390) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,548,650 (1,258,710 - 1,776,290) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,542,000 (1,233,720 - 1,788,760) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,551,020 (1,248,380 - 1,790,440) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,551,480 (1,244,090 - 1,814,450) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,524,900 (1,225,800 - 1,761,400) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,519,090 (1,228,510 - 1,744,930) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,519,340 (1,238,520 - 1,746,000) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,512,710 (1,241,800 - 1,740,720) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,486,970 (1,224,070 - 1,739,410) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,460,250 (1,192,500 - 1,692,970) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,450,320 (1,170,850 - 1,685,150) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,446,410 (1,144,060 - 1,694,920) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,440,050 (1,128,650 - 1,695,900) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,421,370 (1,098,880 - 1,685,940) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,393,800 (1,085,940 - 1,643,180) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,369,000 (1,077,150 - 1,595,490) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,343,010 (1,063,250 - 1,558,230) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,315,450 (1,046,650 - 1,524,330) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,299,360 (1,032,950 - 1,512,480) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,305,310 (1,033,320 - 1,510,090) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,322,930 (1,040,950 - 1,540,930) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,322,890 (1,027,860 - 1,553,080) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,302,150 (1,002,220 - 1,541,160) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,284,080 (981,721 - 1,525,100) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,254,630 (966,372 - 1,474,950) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,210,320 (940,181 - 1,414,000) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,170,900 (916,132 - 1,356,390) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,132,450 (888,565 - 1,311,390) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,081,060 (854,439 - 1,253,020) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 17.9 (13.20 - 23.90) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 25.02 (19.57 - 30.92) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 25.24 (19.87 - 31.10) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 25.11 (19.62 - 31.05) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 25.1 (19.65 - 31.08) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 25.09 (19.64 - 31.25) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 25.2 (19.73 - 31.56) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 25.36 (19.92 - 31.59) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 25.22 (19.80 - 31.46) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 25.3 (19.86 - 31.40) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 25.63 (20.18 - 31.70) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 25.82 (20.31 - 32.46) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 26.32 (20.55 - 33.31) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 26.62 (20.50 - 34.01) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 26.86 (20.54 - 34.87) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 27.36 (20.46 - 36.94) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 26.75 (19.93 - 35.71) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 27.27 (20.43 - 36.28) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 25.7 (19.36 - 32.86) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 24.53 (18.77 - 30.82) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 23.48 (18.14 - 29.76) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 23.01 (17.85 - 29.28) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 22.5 (17.43 - 28.86) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 21.76 (16.71 - 28.28) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 22.09 (16.89 - 28.46) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 21.51 (16.47 - 27.96) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 21.11 (15.98 - 27.58) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 20.1 (15.22 - 26.58) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 18.56 (13.76 - 24.56) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 19.09 (14.21 - 25.43) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 17.93 (13.18 - 23.87) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 2,305 | 2016 | Modelled | WHO |
| 1,611 (1,261 - 1,991) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,562 (1,229 - 1,924) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,720 (1,346 - 2,130) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,667 (1,302 - 2,061) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,782 (1,396 - 2,220) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,834 (1,436 - 2,297) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,993 (1,564 - 2,473) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,887 (1,482 - 2,350) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,942 (1,524 - 2,422) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,033 (1,600 - 2,514) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,062 (1,622 - 2,592) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,136 (1,667 - 2,703) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,209 (1,701 - 2,822) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,275 (1,739 - 2,953) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,354 (1,763 - 3,132) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,410 (1,796 - 3,218) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,411 (1,804 - 3,256) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,370 (1,785 - 3,031) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,320 (1,776 - 2,915) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,280 (1,761 - 2,890) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,304 (1,784 - 2,955) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,294 (1,780 - 2,920) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,322 (1,776 - 2,992) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,349 (1,804 - 3,053) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,384 (1,826 - 3,099) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,402 (1,818 - 3,137) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,347 (1,777 - 3,103) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,285 (1,694 - 3,023) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,288 (1,703 - 3,048) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,267 (1,667 - 3,018) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,267 (1,667 - 3,018) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 47 | 2019 | Survey/reported | WHO/UNICEF |
| 47 | 2020 | Survey/reported | WHO/UNICEF |
| 47 | 2021 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 3.02 (2.42 - 3.81) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.04 (2.44 - 3.81) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.05 (2.44 - 3.80) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.06 (2.45 - 3.80) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.07 (2.47 - 3.81) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.09 (2.50 - 3.83) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.12 (2.52 - 3.86) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.14 (2.55 - 3.89) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.17 (2.56 - 3.94) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.19 (2.59 - 3.99) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.22 (2.59 - 4.02) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.25 (2.61 - 4.05) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.27 (2.63 - 4.09) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.3 (2.66 - 4.14) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.32 (2.66 - 4.17) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.35 (2.68 - 4.19) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.37 (2.71 - 4.22) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.39 (2.73 - 4.24) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.41 (2.76 - 4.26) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.43 (2.78 - 4.30) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.44 (2.78 - 4.30) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.45 (2.78 - 4.32) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.47 (2.79 - 4.35) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.49 (2.80 - 4.37) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.5 (2.81 - 4.38) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.52 (2.84 - 4.40) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.54 (2.87 - 4.42) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.56 (2.89 - 4.45) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.57 (2.88 - 4.48) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.6 (2.90 - 4.52) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.93 (2.34 - 3.69) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 1.45 (1.19 - 1.63) | 2019 | Modelled | Dugan et al., 2021 |
Number of people living with chronic HCV (RNA+/cAg)
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 220,114 (177,424 - 275,725) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 227,629 (183,478 - 284,927) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 233,400 (189,481 - 292,210) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 239,645 (194,301 - 299,799) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 246,936 (199,552 - 308,480) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 252,020 (202,176 - 315,239) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 256,618 (206,510 - 321,927) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 263,644 (212,558 - 331,049) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 268,218 (216,664 - 336,277) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 269,355 (217,975 - 336,956) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 270,445 (219,274 - 338,292) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 273,341 (221,302 - 342,006) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 277,535 (223,718 - 347,872) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 281,055 (226,053 - 352,472) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 284,240 (228,285 - 356,498) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 288,062 (230,445 - 361,559) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 292,221 (235,358 - 366,188) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 296,729 (238,280 - 371,025) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 301,761 (242,354 - 376,675) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 307,119 (247,581 - 382,837) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 312,778 (252,840 - 390,973) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 318,435 (257,373 - 395,887) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 324,030 (262,487 - 401,753) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 329,817 (266,603 - 408,692) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 335,896 (270,827 - 415,825) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 342,416 (275,900 - 423,912) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 349,256 (280,008 - 433,731) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 356,882 (286,151 - 445,197) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 365,010 (293,472 - 458,328) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 370,069 (295,859 - 466,404) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 373,081 (298,723 - 470,120) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 45,300 (37,200 - 50,800) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
Download| Value (Deaths per 100,000) | Year | Type | Source |
|---|---|---|---|
| 3.56 (2.41 - 4.97) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 4.56 (3.30 - 5.93) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.61 (3.33 - 6.03) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.56 (3.32 - 5.93) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.57 (3.33 - 5.95) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.55 (3.31 - 5.91) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.57 (3.35 - 5.96) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.6 (3.36 - 6.13) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.61 (3.34 - 6.06) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.59 (3.34 - 6.04) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.68 (3.41 - 6.28) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.72 (3.39 - 6.29) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.74 (3.35 - 6.32) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.73 (3.34 - 6.32) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.71 (3.35 - 6.33) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.71 (3.37 - 6.24) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.6 (3.29 - 6.10) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.69 (3.37 - 6.15) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.46 (3.23 - 5.97) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.53 (3.26 - 6.02) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.35 (3.10 - 5.81) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.18 (2.97 - 5.75) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.29 (3.06 - 5.82) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.07 (2.86 - 5.61) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.86 (2.69 - 5.38) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.97 (2.77 - 5.49) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.78 (2.60 - 5.25) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.75 (2.59 - 5.26) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.76 (2.62 - 5.23) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.68 (2.52 - 5.11) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.56 (2.41 - 4.97) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 617 | 2016 | Modelled | WHO |
| 450 (305 - 628) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 450 (305 - 628) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 454 (311 - 629) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 451 (314 - 627) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 438 (302 - 614) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 430 (295 - 597) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 428 (298 - 596) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 429 (299 - 592) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 428 (301 - 590) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 428 (304 - 589) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 428 (306 - 581) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 422 (301 - 564) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 422 (306 - 565) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 417 (300 - 555) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 414 (296 - 550) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 413 (297 - 542) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 406 (291 - 538) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 399 (284 - 536) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 392 (277 - 525) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 384 (272 - 512) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 377 (271 - 502) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 371 (271 - 498) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 362 (264 - 483) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 353 (257 - 465) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 343 (248 - 451) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 333 (243 - 434) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 323 (235 - 420) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 312 (228 - 406) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 303 (221 - 395) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 294 (213 - 382) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 285 (206 - 373) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Modelled
HBV
2,267
2019
(1,667 - 3,018)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HBV chart
Modelled
HCV
450
2019
(305 - 628)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HCV chart
Prevalence < 5
HBV
6.07
(%)
2020, latest modelled
(5.10 - 7.24(%))
WHO
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines